Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 6
Submit an article Journal homepage
181
Views
52
CrossRef citations to date
0
Altmetric
Original

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series

Apostolia-Maria Tsimberidou Departments of LeukemiaCorrespondence[email protected]
,
Maribel Tirado-Gomez Experimental Therapeutics
,
Michael Andreeff Blood and Marrow Transplantation, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
,
Susan O'Brien Departments of Leukemia
,
Hagop Kantarjian Departments of Leukemia
,
Michael Keating Departments of Leukemia
,
Gabriel Lopez-Berestein Experimental Therapeutics
&
Elihu Estey Departments of Leukemia
 show all
Pages 1062-1068 | Accepted 01 Nov 2005, Published online: 01 Jul 2009

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gabriel Silva Marques Borges, Flávia Alves Lima, Guilherme Carneiro, Gisele Assis Castro Goulart & Lucas Antônio Miranda Ferreira. (2021) All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks. Expert Opinion on Drug Delivery 18:10, pages 1335-1354.
Read now
Vladimir Torchilin. (2008) Antibody-modified liposomes for cancer chemotherapy. Expert Opinion on Drug Delivery 5:9, pages 1003-1025.
Read now

Articles from other publishers (50)

Yuya Nagai & Alexander J. Ambinder. (2023) The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away. Cancers 15:14, pages 3535.
Crossref
G. Fortin, V. Lallemand-Breitenbach & H. de Thé. (2023) La leucémie aiguë promyélocytaire: un paradigme de la guérison par les traitements ciblés. Bulletin de l'Académie Nationale de Médecine 207:4, pages 423-430.
Crossref
Mohit Saxena, Irappa V. Madabhavi, Apurva Patel, Harsha Panchal & Asha Anand. (2023) Treating low- and intermediate-risk acute promyelocytic leukemia with and without chemotherapy: A comparison in a tertiary care center. Journal of Cancer Research and Therapeutics 19:5, pages 1371-1378.
Crossref
Victoria Korsos & Wilson H Miller Jr. (2022) How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy. Journal of Molecular Endocrinology 69:4, pages T69-T83.
Crossref
Carmelo Gurnari, Maria Teresa Voso, Katia Girardi, Angela Mastronuzzi & Luisa Strocchio. (2021) Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy. International Journal of Molecular Sciences 22:2, pages 642.
Crossref
Daniela Hernandez, Laura Palau, Kelly Norsworthy, Nicole M. Anders, Salvador Alonso, Meng Su, Martin Petkovich, Rosh Chandraratna, Michelle A. Rudek, B. Douglas Smith, Richard J. Jones & Gabriel Ghiaur. (2020) Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids. Leukemia 34:11, pages 3077-3081.
Crossref
Maria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, Federica Rinaldi, Carlotta Marianecci, Isabella Screpanti, Saula Checquolo & Maria Carafa. (2020) Current Trends in ATRA Delivery for Cancer Therapy. Pharmaceutics 12:8, pages 707.
Crossref
Marie-Claude Geoffroy & Hugues de Thé. (2020) Classic and Variants APLs, as Viewed from a Therapy Response. Cancers 12:4, pages 967.
Crossref
Shannon Conneely & Alexandra Stevens. (2020) Advances in Pediatric Acute Promyelocytic Leukemia. Children 7:2, pages 11.
Crossref
Songyin Huang, Yang Chen, Zhi-Mei Liang, Na-Na Li, Yujie Liu, Yinghua Zhu, Dingzhun Liao, Xiao Zhen Zhou, Kun Ping Lu, Yandan Yao & Man-Li Luo. (2019) Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms. Frontiers in Cell and Developmental Biology 7.
Crossref
Zhen Yuan, Liang Zhong, Dongdong Liu, Juanjuan Yao, Junmei Liu, Pengqiang Zhong, Shifei Yao, Yi Zhao, Lianwen Li, Min Chen, Lu Liu & Beizhong Liu. (2019) MiR-15b regulates cell differentiation and survival by targeting CCNE1 in APL cell lines. Cellular Signalling 60, pages 57-64.
Crossref
Ryan W. Holloway, Margaret L. Thomas, Alejandro M. Cohen, Alamelu G. Bharadwaj, Mushfiqur Rahman, Paola Marcato, Paola A. Marignani & David M. Waisman. (2018) Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)☆. Cell Death & Disease 9:9.
Crossref
Lourdes Mendez, Ming Chen & Pier Paolo Pandolfi. 2018. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 41 53 .
Ramy Rahmé, Cécile Esnault & Hugues de Thé. 2018. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 17 27 .
Mary-Elizabeth M. Percival & Elihu H. Estey. 2018. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 133 151 .
Pilar Acedo & Joanna Zawacka-Pankau. (2015) p53 family members — important messengers in cell death signaling in photodynamic therapy of cancer?. Photochemical & Photobiological Sciences 14:8, pages 1389-1396.
Crossref
Jaleh Varshosaz. (2015) Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 21:42, pages 12022.
Crossref
Kim L. Rice & Hugues de Thé. 2015. Chromosomal Translocations and Genome Rearrangements in Cancer. Chromosomal Translocations and Genome Rearrangements in Cancer 251 273 .
Elihu Estey. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 477 487 .
Hugues de Thé, Jun Zhu, Rihab Nasr, Julien Ablain & Valérie Lallemand-Breittenbach. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 461 475 .
Julien Ablain & Hugues de Thé. (2014) Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia. International Journal of Cancer 135:10, pages 2262-2272.
Crossref
K. L. Rice & H. de Thé. (2014) The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies. Journal of Internal Medicine 276:1, pages 61-70.
Crossref
Elizabeth H. Cull & Jessica K. Altman. (2014) Contemporary Treatment of APL. Current Hematologic Malignancy Reports 9:2, pages 193-201.
Crossref
Julien Ablain, Kim Rice, Hassane Soilihi, Aurélien de Reynies, Saverio Minucci & Hugues de Thé. (2014) Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nature Medicine 20:2, pages 167-174.
Crossref
Preetesh Jain, Hagop Kantarjian, Elihu Estey, Sherry Pierce, Jorge Cortes, Gabriel Lopez-Berestein & Farhad Ravandi. (2014) Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data. Clinical Lymphoma Myeloma and Leukemia 14:1, pages e47-e49.
Crossref
Valérie Lallemand-Breittenbach & Hugues de Thé. 2015. Molecular Oncology. Molecular Oncology 769 776 .
Guilherme Augusto dos Santos, Lev Kats & Pier Paolo Pandolfi. (2013) Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia. Journal of Experimental Medicine 210:13, pages 2793-2802.
Crossref
Francesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, Christian Thiede, Sonia Maria Orlando, Simona Iacobelli, Felicetto Ferrara, Paola Fazi, Laura Cicconi, Eros Di Bona, Giorgina Specchia, Simona Sica, Mariadomenica Divona, Alessandro Levis, Walter Fiedler, Elisa Cerqui, Massimo Breccia, Giuseppe Fioritoni, Helmut R. Salih, Mario Cazzola, Lorella Melillo, Angelo M. Carella, Christian H. Brandts, Enrica Morra, Marie von Lilienfeld-Toal, Bernd Hertenstein, Mohammed Wattad, Michael Lübbert, Matthias Hänel, Norbert Schmitz, Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk & Uwe Platzbecker. (2013) Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. New England Journal of Medicine 369:2, pages 111-121.
Crossref
Bo JiaoZhi-Hong RenPing LiuLi-Juan ChenJing-Yi ShiYing DongJulien Ablain, Lin ShiLi GaoJun-Pei HuRui-Bao RenHugues de Thé, Zhu Chen & Sai-Juan Chen. (2013) 8-CPT-cAMP/all- trans retinoic acid targets t (11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation . Proceedings of the National Academy of Sciences 110:9, pages 3495-3500.
Crossref
Jaleh Varshosaz, Farshid Hassanzadeh, Hojjat Sadeghi, Zahra Ghelich Khan & Mahboobeh Rostami. (2013) Retinoic Acid Decorated Albumin-Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular Carcinoma. Journal of Nanomaterials 2013, pages 1-12.
Crossref
I.A. Shmarakov & N.V. Katan. (2012) The induction of guerin's carcinoma cytochrome P450 hydroxylase activity by retinoids. Biomeditsinskaya Khimiya 58:5, pages 539-548.
Crossref
Mindy Farris, Astrid Lague, Zara Manuelyan, Jacob Statnekov & Christopher Francklyn. (2012) Altered nuclear cofactor switching in retinoic-resistant variants of the PML-RAR? oncoprotein of acute promyelocytic leukemia. Proteins: Structure, Function, and Bioinformatics 80:4, pages 1095-1109.
Crossref
Valerie Lallemand-Breitenbach, Jun Zhu, Zhu Chen & Hugues de Thé. (2012) Curing APL through PML/RARA degradation by As2O3. Trends in Molecular Medicine 18:1, pages 36-42.
Crossref
Valeria Cambiaghi, Virginia Giuliani, Sara Lombardi, Cristiano Marinelli, Francesca Toffalorio & Pier Giuseppe Pelicci. 2012. TRIM/RBCC Proteins. TRIM/RBCC Proteins 77 91 .
Vladimir Torchilin. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery 289 328 .
I. A. Shmarakov & N. V. Katan. (2011) The induction of Guerin?s carcinoma cytochrome P450 hydroxylase activity by retinoids. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 5:4, pages 369-375.
Crossref
Vladimir P. Torchilin. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 951 987 .
Elihu H. Estey. (2011) Newly Diagnosed Acute Promyelocytic Leukemia: Arsenic Moves Front and Center. Journal of Clinical Oncology 29:20, pages 2743-2746.
Crossref
Julien Ablain & Hugues de The. (2011) Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood 117:22, pages 5795-5802.
Crossref
V Pavet, M M Portal, J C Moulin, R Herbrecht & H Gronemeyer. (2010) Towards novel paradigms for cancer therapy. Oncogene 30:1, pages 1-20.
Crossref
Hugues de Thé & Zhu Chen. (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nature Reviews Cancer 10:11, pages 775-783.
Crossref
Rihab Nasr & Hugues de Thé. (2010) Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting. International Journal of Hematology 91:5, pages 742-747.
Crossref
Rihab Nasr, Valérie Lallemand-Breitenbach, Jun Zhu, Marie-Claude Guillemin & Hugues de Thé. (2009) Therapy-induced PML/RARA Proteolysis and Acute Promyelocytic Leukemia Cure . Clinical Cancer Research 15:20, pages 6321-6326.
Crossref
Scott C. Kogan. (2009) Curing APL: Differentiation or Destruction?. Cancer Cell 15:1, pages 7-8.
Crossref
Rihab Nasr, Marie-Claude Guillemin, Omar Ferhi, Hassan Soilihi, Laurent Peres, Caroline Berthier, Philippe Rousselot, Macarena Robledo-Sarmiento, Valérie Lallemand-Breitenbach, Bernard Gourmel, Dominique Vitoux, Pier Paolo Pandolfi, Cécile Rochette-Egly, Jun Zhu & Hugues de Thé. (2008) Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nature Medicine 14:12, pages 1333-1342.
Crossref
E. Patatanian & D. F. Thompson. (2008) Retinoic acid syndrome: a review. Journal of Clinical Pharmacy and Therapeutics 33:4, pages 331-338.
Crossref
Nigel P. Mongan & Lorraine J. Gudas. (2007) Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75:9, pages 853-870.
Crossref
Joseph G. Jurcic, Steven L. Soignet & Peter G. Maslak. (2007) Diagnosis and treatment of acute promyelocytic leukemia. Current Oncology Reports 9:5, pages 337-344.
Crossref
Sheryl A. Flanagan & Kelly A. Meckling. (2007) Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acid. Leukemia Research 31:7, pages 955-968.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:1, pages 44-51.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.